← Open Payments lookup

ANGELA STERLING: Open Payments

NPI 1578720231 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,025 in 49 payments from 14 companies in 2025. Trend: 2023 $852 · 2024 $900 · 2025 $1,025

Food & beverage: $1,025
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation17$329
AstraZeneca Pharmaceuticals LP2$145
Merck Sharp & Dohme LLC4$91
Bayer Healthcare Pharmaceuticals Inc.4$76
SCPHARMACEUTICALS INC.4$74
E.R. Squibb & Sons, L.L.C.3$56
Esperion Therapeutics, Inc.3$54
Medtronic, Inc.1$44
Alnylam Pharmaceuticals Inc.2$36
Boehringer Ingelheim Pharmaceuticals, Inc.2$32

Products named: LEQVIO, LOKELMA, Kerendia, FUROSCIX, VERQUVO, NEXLETOL, ELIQUIS, SYMPLICITY G3.

Industry payments across MS — which companies pay providers there.